These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24647827)

  • 1. Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.
    Logan R; Kong AC; Axcell E; Krise JP
    J Pharm Sci; 2014 May; 103(5):1572-80. PubMed ID: 24647827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
    Logan R; Kong A; Krise JP
    J Pharm Sci; 2013 Nov; 102(11):4173-80. PubMed ID: 23970383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.
    Logan R; Kong AC; Krise JP
    J Pharm Sci; 2014 Oct; 103(10):3287-96. PubMed ID: 25042198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99.
    Lemieux B; Percival MD; Falgueyret JP
    Anal Biochem; 2004 Apr; 327(2):247-51. PubMed ID: 15051542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.
    Funk RS; Krise JP
    Mol Pharm; 2012 May; 9(5):1384-95. PubMed ID: 22449202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high content screening assay for identifying lysosomotropic compounds.
    Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y
    Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
    Logan R; Funk RS; Axcell E; Krise JP
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system.
    Kornhuber J; Henkel AW; Groemer TW; Städtler S; Welzel O; Tripal P; Rotter A; Bleich S; Trapp S
    J Cell Physiol; 2010 Jul; 224(1):152-64. PubMed ID: 20301195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
    Firestone RA; Pisano JM; Bonney RJ
    J Med Chem; 1979 Sep; 22(9):1130-3. PubMed ID: 114658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal adaptation: How cells respond to lysosomotropic compounds.
    Lu S; Sung T; Lin N; Abraham RT; Jessen BA
    PLoS One; 2017; 12(3):e0173771. PubMed ID: 28301521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
    Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
    Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications.
    Kaufmann AM; Krise JP
    J Pharm Sci; 2007 Apr; 96(4):729-46. PubMed ID: 17117426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes.
    Schmitt MV; Lienau P; Fricker G; Reichel A
    Drug Metab Dispos; 2019 Jan; 47(1):49-57. PubMed ID: 30409837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal localization and mechanism of uptake of Nile blue photosensitizers in tumor cells.
    Lin CW; Shulok JR; Kirley SD; Cincotta L; Foley JW
    Cancer Res; 1991 May; 51(10):2710-9. PubMed ID: 2021950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
    Kazmi F; Hensley T; Pope C; Funk RS; Loewen GJ; Buckley DB; Parkinson A
    Drug Metab Dispos; 2013 Apr; 41(4):897-905. PubMed ID: 23378628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function.
    Pisonero-Vaquero S; Medina DL
    Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death.
    Villamil Giraldo AM; Appelqvist H; Ederth T; Öllinger K
    Biochem Soc Trans; 2014 Oct; 42(5):1460-4. PubMed ID: 25233432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of 3T3 fibroblasts by lysosomotropic amines: correlation with effects on intravesicular pH but not vacuolation.
    Cain CC; Murphy RF
    J Cell Physiol; 1986 Oct; 129(1):65-70. PubMed ID: 3760033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between promazine and antidepressants at the level of cellular distribution.
    Daniel WA; Wójcikowski J
    Pharmacol Toxicol; 1997 Dec; 81(6):259-64. PubMed ID: 9444666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lysosomotropic molecules on cellular homeostasis.
    Kuzu OF; Toprak M; Noory MA; Robertson GP
    Pharmacol Res; 2017 Mar; 117():177-184. PubMed ID: 28025106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.